Bavarian Nordic has repeated a recommendation that its shareholders accept a takeover offer from an investment consortium, saying updated terms are "fair and attractive." The Danish biopharma company ...
Johnson & Johnson has halved the size of its collaboration with Bavarian Nordic on vaccine development, jettisoning its stake in shots targeting human papillomavirus (HPV) and hepatitis B virus (HBV).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback